Showing results (61-70 of 129) with videos related to
Sort By:
Pageof 13
Journal of Autoimmunity|August 2, 2003
Cluster analysis of human autoantibody reactivities in health and in type 1 diabetes mellitus: a bio-informatic approach to immune complexityFrancisco J Quintana, Gad Getz, Guy Hed, et al.Plos Pathogens|September 9, 2010
HIV-1 gp41 and TCRalpha trans-membrane domains share a motif exploited by the HIV virus to modulate T-cell proliferationTomer Cohen, Shmuel Jaffe Cohen, Niv Antonovsky, et al.Immunology|April 19, 2017
Activation of the Akt-CREB signalling axis by a proline-rich heptapeptide confers resistance to stress-induced cell death and inflammationJohannes Herkel, Jörg Schrader, Neta Erez, et al.International Immunology|August 9, 2006
Peptide p277 of HSP60 signals T cells: inhibition of inflammatory chemotaxisGabriel Nussbaum, Alexandra Zanin-Zhorov, Francisco Quintana, et al.Journal of Autoimmunity|June 7, 2003
T cells and autoantibodies to human HSP70 in type 1 diabetes in childrenRivka Abulafia-Lapid, David Gillis, Orit Yosef, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 26, 2003
T cells respond to heat shock protein 60 via TLR2: activation of adhesion and inhibition of chemokine receptorsAlexandra Zanin-Zhorov, Gabriel Nussbaum, Susanne Franitza, et al.Biochemistry|April 2, 2008
Characterization of the interacting domain of the HIV-1 fusion peptide with the transmembrane domain of the T-cell receptorTomer Cohen, Meirav Pevsner-Fischer, Noam Cohen, et al.Biochemistry|February 10, 2007
A structurally altered D,L-amino acid TCRalpha transmembrane peptide interacts with the TCRalpha and inhibits T-cell activation in vitro and in an animal modelFrancisco J Quintana, Doron Gerber, Itai Bloch, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 30, 2004
T-cell vaccination against anti-CD4 autoimmunity in HIV-1 infected patientsRivka Abulafia-Lapid, Zvi Bentwich, Yael Keren-Zur, et al.The Journal of Clinical Investigation|July 12, 2005
HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activationFrancisco J Quintana, Doron Gerber, Sally C Kent, et al.Pageof 13